13-24316163-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_178540.5(C1QTNF9):​c.160G>A​(p.Asp54Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000294 in 1,598,960 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000028 ( 1 hom. )

Consequence

C1QTNF9
NM_178540.5 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.64
Variant links:
Genes affected
C1QTNF9 (HGNC:28732): (C1q and TNF related 9) Enables identical protein binding activity. Predicted to be involved in signal transduction. Predicted to be located in extracellular region. Predicted to be part of collagen trimer. [provided by Alliance of Genome Resources, Apr 2022]
C1QTNF9-AS1 (HGNC:39906): (C1QTNF9 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22762394).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
C1QTNF9NM_178540.5 linkuse as main transcriptc.160G>A p.Asp54Asn missense_variant 2/4 ENST00000332018.5
C1QTNF9NM_001303137.2 linkuse as main transcriptc.160G>A p.Asp54Asn missense_variant 3/5
C1QTNF9NM_001303138.2 linkuse as main transcriptc.160G>A p.Asp54Asn missense_variant 2/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
C1QTNF9ENST00000332018.5 linkuse as main transcriptc.160G>A p.Asp54Asn missense_variant 2/41 NM_178540.5 P1
C1QTNF9-AS1ENST00000449656.1 linkuse as main transcriptn.74-42C>T intron_variant, non_coding_transcript_variant 5
C1QTNF9ENST00000382071.6 linkuse as main transcriptc.160G>A p.Asp54Asn missense_variant 2/45 P1

Frequencies

GnomAD3 genomes
AF:
0.0000398
AC:
6
AN:
150912
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000122
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000663
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000453
AC:
11
AN:
242892
Hom.:
0
AF XY:
0.0000305
AC XY:
4
AN XY:
131164
show subpopulations
Gnomad AFR exome
AF:
0.000187
Gnomad AMR exome
AF:
0.0000296
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000240
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000283
AC:
41
AN:
1447930
Hom.:
1
Cov.:
32
AF XY:
0.0000376
AC XY:
27
AN XY:
718978
show subpopulations
Gnomad4 AFR exome
AF:
0.000151
Gnomad4 AMR exome
AF:
0.0000227
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000341
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000363
Gnomad4 OTH exome
AF:
0.0000335
GnomAD4 genome
AF:
0.0000397
AC:
6
AN:
151030
Hom.:
0
Cov.:
30
AF XY:
0.0000543
AC XY:
4
AN XY:
73714
show subpopulations
Gnomad4 AFR
AF:
0.000122
Gnomad4 AMR
AF:
0.0000662
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.0000659
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 31, 2023The c.160G>A (p.D54N) alteration is located in exon 2 (coding exon 1) of the C1QTNF9 gene. This alteration results from a G to A substitution at nucleotide position 160, causing the aspartic acid (D) at amino acid position 54 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.32
T;T
Eigen
Benign
0.14
Eigen_PC
Benign
0.21
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.80
.;T
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.23
T;T
MetaSVM
Uncertain
0.46
D
MutationAssessor
Benign
1.4
L;L
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-1.7
N;N
REVEL
Uncertain
0.41
Sift
Benign
0.18
T;T
Sift4G
Benign
0.26
T;T
Polyphen
0.51
P;P
Vest4
0.26
MutPred
0.36
Gain of catalytic residue at K52 (P = 0.003);Gain of catalytic residue at K52 (P = 0.003);
MVP
0.88
ClinPred
0.068
T
GERP RS
3.9
Varity_R
0.21
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs766110595; hg19: chr13-24890301; API